Wordt geladen...
Interim Futility Monitoring Assessing Immune Therapies With a Potentially Delayed Treatment Effect
PURPOSE: Introduction of new immune therapies that may have a delayed beneficial effect necessitates re-evaluation of traditional clinical trial designs in oncology. A key design feature of randomized trials is interim futility monitoring, which allows stopping early if the accruing data convincingl...
Bewaard in:
| Gepubliceerd in: | J Clin Oncol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Clinical Oncology
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366306/ https://ncbi.nlm.nih.gov/pubmed/29949395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2018.77.7144 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|